Verónica Vidal

1.1k total citations
36 papers, 658 citations indexed

About

Verónica Vidal is a scholar working on Public Health, Environmental and Occupational Health, Genetics and Physiology. According to data from OpenAlex, Verónica Vidal has authored 36 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Public Health, Environmental and Occupational Health, 10 papers in Genetics and 8 papers in Physiology. Recurrent topics in Verónica Vidal's work include Down syndrome and intellectual disability research (13 papers), Alzheimer's disease research and treatments (8 papers) and Genetics and Neurodevelopmental Disorders (8 papers). Verónica Vidal is often cited by papers focused on Down syndrome and intellectual disability research (13 papers), Alzheimer's disease research and treatments (8 papers) and Genetics and Neurodevelopmental Disorders (8 papers). Verónica Vidal collaborates with scholars based in Spain, United States and Italy. Verónica Vidal's co-authors include Carmen Martínez‐Cué, Susana García-Cerro, Noemı́ Rueda, Andrea Corrales, Paula Martínez, Jesús Flórez, Rebeca Vidal, Emilio J. Sánchez‐Barceló, Eva María Pérez García and María L. Arbonés and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Scientific Reports.

In The Last Decade

Verónica Vidal

34 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Verónica Vidal Spain 15 311 201 170 163 93 36 658
Benoît Souchet France 11 292 0.9× 220 1.1× 224 1.3× 156 1.0× 61 0.7× 20 695
Mustafa Ayberk Kurt Türkiye 16 162 0.5× 238 1.2× 128 0.8× 281 1.7× 45 0.5× 31 857
Gabriella Horváth Canada 18 81 0.3× 465 2.3× 171 1.0× 109 0.7× 13 0.1× 59 896
Gerard Callejo Spain 17 133 0.4× 427 2.1× 25 0.1× 439 2.7× 25 0.3× 27 1.0k
Lynda Whiting New Zealand 13 229 0.7× 238 1.2× 83 0.5× 190 1.2× 10 0.1× 20 700
Michael J. Cools United States 8 74 0.2× 176 0.9× 68 0.4× 35 0.2× 41 0.4× 26 548
Thomas E. Childs United States 14 53 0.2× 400 2.0× 107 0.6× 370 2.3× 9 0.1× 30 771
Yeimy González‐Giraldo Colombia 12 24 0.1× 292 1.5× 63 0.4× 232 1.4× 36 0.4× 38 668
Yoshimi Sogawa United States 17 86 0.3× 193 1.0× 78 0.5× 90 0.6× 197 2.1× 44 1.1k
A. Di Lieto Italy 12 46 0.1× 160 0.8× 30 0.2× 48 0.3× 41 0.4× 32 551

Countries citing papers authored by Verónica Vidal

Since Specialization
Citations

This map shows the geographic impact of Verónica Vidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verónica Vidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verónica Vidal more than expected).

Fields of papers citing papers by Verónica Vidal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verónica Vidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verónica Vidal. The network helps show where Verónica Vidal may publish in the future.

Co-authorship network of co-authors of Verónica Vidal

This figure shows the co-authorship network connecting the top 25 collaborators of Verónica Vidal. A scholar is included among the top collaborators of Verónica Vidal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verónica Vidal. Verónica Vidal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rúmiz, Eva, Ernesto Valero, Alberto Berenguer, et al.. (2023). Long-term recurrent events in ST-elevation myocardial infarction and multivessel disease. The impact of different revascularization strategies. Revista Portuguesa de Cardiologia. 42(5). 445–451.
3.
Breinbauer, Cecilia, et al.. (2022). Early Childhood Development policy in Chile: Progress and pitfalls supporting children with developmental disabilities toward school readiness. Frontiers in Public Health. 10. 983513–983513. 3 indexed citations
4.
Miranda, Carolina, et al.. (2021). Correlation between systemic iron parameters and substantia nigra iron stores in restless legs syndrome. Sleep Medicine. 85. 191–195. 9 indexed citations
5.
Vidal, Verónica, Susana García-Cerro, Maria Teresa Garcı́a-Unzueta, et al.. (2021). Bexarotene Impairs Cognition and Produces Hypothyroidism in a Mouse Model of Down Syndrome and Alzheimer’s Disease. Frontiers in Pharmacology. 12. 613211–613211. 10 indexed citations
6.
Vidal, Verónica, Olga Gutiérrez, Ana Talamillo, Carlos Velásquez, & José L. Fernández-Luna. (2021). Glioblastoma invasion factor ODZ1 is induced by microenvironmental signals through activation of a Stat3-dependent transcriptional pathway. Scientific Reports. 11(1). 16196–16196. 5 indexed citations
7.
Rueda, Noemı́, Verónica Vidal, Susana García-Cerro, et al.. (2020). Prenatal, but not Postnatal, Curcumin Administration Rescues Neuromorphological and Cognitive Alterations in Ts65Dn Down Syndrome Mice. Journal of Nutrition. 150(9). 2478–2489. 12 indexed citations
8.
Espriella, Rafael de la, Antoni Bayés‐Genís, Verónica Vidal, et al.. (2020). Renal Function Dynamics Following Co-Administration of Sacubitril/Valsartan and Empagliflozin in Patients with Heart Failure and Type 2 Diabetes. ESC Heart Failure. 7(6). 3792–3800. 10 indexed citations
9.
10.
Giacomini, Andrea, Fiorenza Stagni, Marco Emili, et al.. (2018). Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome. Brain Research Bulletin. 140. 378–391. 15 indexed citations
11.
Ríos‐Navarro, César, José Gavara, Verónica Vidal, et al.. (2018). Characterization and implications of the dynamics of eosinophils in blood and in the infarcted myocardium after coronary reperfusion. PLoS ONE. 13(10). e0206344–e0206344. 25 indexed citations
12.
Rueda, Noemı́, Verónica Vidal, Susana García-Cerro, et al.. (2018). Anti-IL17 treatment ameliorates Down syndrome phenotypes in mice. Brain Behavior and Immunity. 73. 235–251. 23 indexed citations
13.
Vidal, Verónica, et al.. (2018). Anticoagulation in Patients with Ischaemic Heart Disease and Peripheral Arterial Disease: Clinical Implications of COMPASS Study. European Cardiology Review. 13(2). 115–115. 7 indexed citations
14.
García-Cerro, Susana, et al.. (2017). Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes. Neurobiology of Disease. 106. 76–88. 64 indexed citations
15.
García-Cerro, Susana, Verónica Vidal, Marı́a T. Berciano, et al.. (2017). Cerebellar alterations in a model of Down syndrome: The role of the Dyrk1A gene. Neurobiology of Disease. 110. 206–217. 14 indexed citations
16.
Parisotto, Eduardo Benedetti, Verónica Vidal, Susana García-Cerro, et al.. (2016). Chronic Melatonin Administration Reduced Oxidative Damage and Cellular Senescence in the Hippocampus of a Mouse Model of Down Syndrome. Neurochemical Research. 41(11). 2904–2913. 29 indexed citations
17.
Izco, María, Paula Martínez, Andrea Corrales, et al.. (2014). Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer’s disease. Neuroscience. 263. 269–279. 35 indexed citations
18.
García-Cerro, Susana, Paula Martínez, Verónica Vidal, et al.. (2014). Overexpression of Dyrk1A Is Implicated in Several Cognitive, Electrophysiological and Neuromorphological Alterations Found in a Mouse Model of Down Syndrome. PLoS ONE. 9(9). e106572–e106572. 77 indexed citations
19.
Martínez‐Cué, Carmen, Paula Martínez, Noemı́ Rueda, et al.. (2013). Reducing GABA A α5 Receptor-Mediated Inhibition Rescues Functional and Neuromorphological Deficits in a Mouse Model of Down Syndrome. Journal of Neuroscience. 33(9). 3953–3966. 122 indexed citations
20.
Vidal, Verónica, Susana García-Cerro, Paula Martínez, et al.. (2012). Lack of behavioral and cognitive effects of chronic ethosuximide and gabapentin treatment in the Ts65Dn mouse model of Down syndrome. Neuroscience. 220. 158–168. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benoît Souchet Breakdown of academic impact, for papers by Mustafa Ayberk Kurt Breakdown of academic impact, for papers by Gabriella Horváth Breakdown of academic impact, for papers by Gerard Callejo Breakdown of academic impact, for papers by Lynda Whiting Breakdown of academic impact, for papers by Michael J. Cools Breakdown of academic impact, for papers by Thomas E. Childs Breakdown of academic impact, for papers by Yeimy González‐Giraldo Breakdown of academic impact, for papers by Yoshimi Sogawa Breakdown of academic impact, for papers by A. Di Lieto
Rankless by CCL
2026